Examples of 'immediate-release exenatide' in a sentence
Meaning of "immediate-release exenatide"
Immediate-release exenatide refers to a form of the medication exenatide that is designed to be rapidly absorbed by the body. It is typically used to help control blood sugar levels in individuals with type 2 diabetes. This formulation of exenatide is intended for immediate effect, as opposed to the extended-release versions that provide a more steady and prolonged release of the medication
How to use "immediate-release exenatide" in a sentence
Basic
Advanced
immediate-release exenatide
Immediate-release exenatide reduced fasting serum glucose by.
There were no episodes of major hypoglycaemia in the immediate-release exenatide arm.
Immediate-release exenatide should not be administered after a meal.
Patients may experience hypoglycaemia when immediate-release exenatide is used with a sulphonylurea.
Immediate-release exenatide must not be administered by intravenous or intramuscular injection.
Most adverse reactions associated with immediate-release exenatide were mild to moderate in intensity.
Immediate-release exenatide has shown no adverse effects on lipid parameters.
These medicinal products should be taken in a standardised way in relation to immediate-release exenatide injection.
Studies of immediate-release exenatide in combination with basal insulin.
Mean daily blood glucose values were similar between immediate-release exenatide and insulin.
Studies of immediate-release exenatide with metformin, a sulphonylurea or both as background therapy.
Premeal blood glucose concentrations were generally lower in patients taking insulin compared to immediate-release exenatide.
Studies of immediate-release exenatide with metformin, a thiazolidinedione or both as background therapy.
In these studies the incidence of hypoglycaemia was similar for immediate-release exenatide and insulin treatment.
Immediate-release exenatide and basal insulin must be administered as two separate injections.
A delay in tmax of about 2 h was observed when warfarin was administered 35 min after immediate-release exenatide.
Immediate-release exenatide use can be continued when a basal insulin is added to existing therapy.
The following interaction studies have been conducted using 10 mcg immediate-release exenatide but not prolonged-release exenatide.
Immediate-release exenatide lowered HbA1c from.
Mean difference in change from baseline versus immediate-release exenatide 95 %.
All patients assigned to immediate-release exenatide initially received 5 mcg BID for four weeks.
Immediate-release exenatide is available as either a 5 mcg or a 10 mcg exenatide per dose pre-filled pen.
Bydureon BCise demonstrated superiority to immediate-release exenatide in reducing HbA1c from baseline to Week 28 ( Table 2 ).
Immediate-release exenatide 5 mcg BID.
Table 1, Adverse reactions of immediate-release exenatide identified from clinical trials and spontaneous reports.
You'll also be interested in:
Examples of using Exenatide
Show more
It is unknown whether exenatide is excreted in human milk
Exenatide belonging to the group of incretin mimetics
Bydureon contains the active substance exenatide
Examples of using Immediate-release
Show more
She continues to require immediate-release morphine
Immediate-release exenatide reduced fasting serum glucose by
The composition may be an immediate-release composition
